Evidence that geniposide abrogates norepinephrine-induced hypopigmentation by the activation of GLP-1R-dependent c-kit receptor signaling in melanocyte

Journal of Ethnopharmacology

Volumn 118, Issue 1, 2008, Pages 154-158

  Wen Jun, Lan ^a   Hai Yan, Wang ^a   Wei, Lan ^b   Ke Yu, Wang ^c   Rui Ming, Wang ^a  

^a QILU UNIVERSITY OF TECHNOLOGY   (China)

^b XINJIANG MEDICAL UNIVERSITY   (China)

^c SHANDONG UNIVERSITY   (China)

Author keywords

c kit; Geniposide (GP); Hypopigmentation; Norepinephrine (NE); Normal human epidermal melanocyte (HEMn)

Indexed keywords

EXENDIN 9-39; GENIPOSIDE; GLUCAGON LIKE PEPTIDE 1 RECEPTOR; GLUCAGON LIKE PEPTIDE 1 RECEPTOR ANTAGONIST; NORADRENALIN; STEM CELL FACTOR RECEPTOR; TYROSINE;

ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; GARDENIA JASMINOIDES; HUMAN; HUMAN CELL; HYPOPIGMENTATION; KERATINOCYTE; MEDICINAL PLANT; MELANOCYTE; MELANOGENESIS; SPECTROPHOTOMETRY; UPREGULATION; VITILIGO VULGARIS;

CELL LINE; FLOW CYTOMETRY; GARDENIA; HUMANS; HYPOPIGMENTATION; IRIDOIDS; KERATINOCYTES; MEDICINE, CHINESE TRADITIONAL; MELANOCYTES; NOREPINEPHRINE; PROTO-ONCOGENE PROTEINS C-KIT; RECEPTORS, GLUCAGON; SIGNAL TRANSDUCTION; UP-REGULATION; VITILIGO;

GARDENIA ANGUSTA;

EID: 44149124834     PISSN: 03788741     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jep.2008.03.021     Document Type: Article

References (29)

1. Berens W., Bossche K.V.D., Yoon T.J., Westbroek W., Valencia J.C., Out C.J., Marie Naeyaert J., Hearing V.J., and Lambert J. Different approaches for assaying melanosome transfer. Pigment Cell Research 18 (2005) 370-381
2. Berger S.A. Signaling pathways influencing SLF and c-kit-mediated survival and proliferation. Immunologic Research 35 (2006) 1-12
3. Bessou S., Gauthier Y., Surleve-Bazeille J.E., Pain C., and Taieb A. Epidermal reconstructs in vitiligo: an extrinsic factor is needed to trigger the disease. The British Journal of Dermatology 137 (1997) 890-897
4. Cario-Andre M., Gauthier Y., Pain C., and Taieb A. SP-21 ex vivo vitiligo vs. control melanocytes susceptibility to catecholamines and hydrogen peroxide. Pigment Cell Research 16 (2003) 587-588
5. Cooksey C.J., Garratt P.J., Land E.J., Paveli S., Ramsden C.A., Riley P.A., and Smiti N.P.M. Evidence of the indirect formation of the catecholic intermediate substrate responsible for the autoactivation kinetics of tyrosinase. The Journal of Biological Chemistry 272 (1997) 26226-26235
6. Drucker D.J., Philippe J., Mojsov S., Chick W.L., and Habener J.F. Glucagon-like peptide I stimulates insulin gene expression and increases cyclic AMP levels in a rat islet cell line. Proceedings of the National Academy of Sciences of the United States of America 84 (1987) 3434-3438
7. Friedmann P.S., and Gilchrest B.A. Ultraviolet radiation directly induces pigment production by cultured human melanocytes. Journal of Cellular Physiology 133 (1987) 88-94
8. Gauthier Y., Cario-Andre M., Lepreux S., Pain C., and Taieb A. Melanocyte detachment after skin friction in non lesional skin of patients with generalized vitiligo. The British Journal of Dermatology 148 (2003) 95-101
9. Hachiya A., Kobayashi A., Ohuchi A., Takema Y., and Imokawa G. The paracrine role of stem cell factor/c-kit signaling in the activation of human melanocytes in ultraviolet-B-Induced pigmentation. The Journal of Investigative Dermatology 116 (2001) 578-586
10. Hachiya A., Kobayashi A., Yoshida Y., Kitahara T., Takema Y., and Imokawa G. Biphasic expression of two paracrine melanogenic cytokines, stem cell factor and endothelin-1, in ultraviolet B-induced human melanogenesis. The American Journal of Pathology 165 (2004) 2099-2109
11. Hemesath T.J., Price E.R., Takemoto C., Badalian T., and Fisher D.E. MAP kinase links the transcription factor microphthalmia to c-Kit signaling in melanocytes. Nature 391 (1998) 298-301
12. Hou L., Panthier J.J., and Arnheiter H. Signaling and transcriptional regulation in the neural crest-derived melanocyte lineage: interactions between KIT and MITF. Development 127 (2000) 5379-5389
13. Huang S., Luca M., Gutman M., McConkey D.J., Langley K.E., Lyman S.D., and Bar-Eli M. Enforced c-KIT expression renders highly metastatic human melanoma cells susceptible to stem cell factor-induced apoptosis and inhibits their tumorigenic and metastatic potential. Oncogene 13 (1996) 2339-2347
14. Imokawa G. Autocrine and paracrine regulation of melanocytes in human skin and in pigmentary disorders. Pigment Cell Research 17 (2004) 96-110
15. Kitamura R., Tsukamoto K., Harada K., Shimizu A., Shimada S., Kobayashi T., and Imokawa G. Mechanisms underlying the dysfunction of melanocytes in vitiligo epidermis: role of SCF/KIT protein interactions and its downstream effector, MITF-M. The Journal of Pathology 202 (2004) 463-475
16. Kuo W.H., Chou F.P., Young S.C., Chang Y.C., and Wang C.J. Geniposide activates GSH S-transferase by the induction of GST M1 and GST M2 subunits involving the transcription and phosphorylation of MEK-1 signaling in rat hepatocytes. Toxicology and Applied Pharmacology 208 (2005) 155-162
17. Lee Y.A., Kim N.H., Choi W.I., and Youm Y.H. Less keratinocyte-derived factors related to more keratinocyte apoptosis in depigmented than normally pigmented suction-blistered epidermis may cause passive melanocyte death in vitiligo. The Journal of Investigative Dermatology 124 (2005) 976-983
18. Liu J., Zheng X., Yin F., Hu Y., Guo L., Deng X., Chen G., Jiajia J., and Zhang H. Neurotrophic property of geniposide for inducing the neuronal differentiation of PC12 cells. International Journal of Developmental Neuroscience: The Official Journal of The International Society for Developmental Neuroscience 24 (2006) 419-424
19. Longley B.J., Morganroth G.S., Tyrrell L., Ding T., Gerson D.M., Williams D.E., and Halaban R. Altered metabolism of mast-cell growth factor (c-kit ligand) in cutaneous mastocytosis. The New England Journal of Medicine 328 (1993) 1302-1307
20. Maeda K., and Fukuda M. Arbutin: mechanism of its depigmenting action in human melanocyte culture. The Journal of Pharmacology and Experimental Therapeutics 276 (1996) 765-769
21. Moretti S., Spallanzani A., Amato L., Hautmann G., Gallerani I., Fabiani M., and Fabbri P. New insights into the pathogenesis of vitiligo: imbalance of epidermal cytokines at sites of lesions. Pigment Cell Research 15 (2002) 87-92
22. Namazi M.R. Prescribing cyclic antidepressants for vitiligo patients: which agents are superior, which are not?. Psychotherapy and Psychosomatics 72 (2003) 361-362
23. Norris A., Todd C., Graham A., Quinn A.G., and Thody A.J. The expression of the c-kit receptor by epidermal melanocytes may be reduced in vitiligo. The British Journal of Dermatology 134 (1996) 299-306
24. Orecchia G.E. Neural pathogenesis. In: Hann S.K., and Nordlund J.J. (Eds). Vitiligo. 1 (2000), Blackwell Scientific Publications, Oxford 142-150
25. Prignano F., Gerlini G., Salvatori B., Orlando C., Mazzoli S., Pimpinelli N., and Moretti S. Stem cell factor affects tumour progression markers in metastatic melanoma cells. Clinical & Experimental Metastasis 23 (2006) 177-186
26. Sakai A. Inhibition of endothelial cell adhesion molecule expression with SJC13, an azaindolidine derivative, in vitro. Inflammation Research: Official Journal of The European Histamine Research Society...[et al.] 45 (1996) 224-229
27. Schallreuter K.U. Epidermal adrenergic signal transduction as part of the neuronal network in the human epidermis. The Journal of Investigative Dermatology. Symposium Proceedings/the Society for Investigative Dermatology, Inc. [and] European Society for Dermatological Research 2 (1997) 37-40
28. Takeyama R., Takekoshi S., Nagata H., Osamura R.Y., and Kawana S. Quercetin-induced melanogenesis in a reconstituted three-dimensional human epidermal model. Journal of Molecular Histology 35 (2004) 157-165
29. Wankowicz-Kalinska A., van den Wijngaard R.M., Tiggers B.J., Westerhof W., Ogg G.S., Cerundolo V., Storkus W.J., and Das P.K. Immunopolarization of CD4+ and CD8+ T cells to type-1-like is associated with melanocyte loss in human vitiligo. Laboratory Investigation; a Journal of Technical Methods and Pathology 83 (2003) 683-695